pharma · Crohn's Disease · Ulcerative Colitis (UC)
AbbVie
AbbVie trial registry — 46 ClinicalTrials.gov studies with program phase, status, and indication context.
1 Waukegan Road, North Chicago, Illinois 60064, US HQ
60,084 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 1 Waukegan Road, North Chicago, Illinois 60064, US
- Employees
- 60,084
- Programs
- 41
- Drugs
- 32
- Patents
- 25
AbbVie clinical trials
Registry index of 46 ClinicalTrials.gov studies linked to AbbVie programs — each row shows trial ID, program name, phase, status, and indication.
AbbVie trial registry — 46 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for AbbVie.
-
Upadacitinib — Phase 3
Clinical update -
Placebo to Upadacitinib — Phase 3
Clinical update -
placebo for risankizumab IV — Phase 3
Clinical update -
placebo for risankizumab — Phase 3
Clinical update -
Placebo for Adalimumab — Phase 3
Clinical update -
Mirvetuximab soravtansine plus Bevacizumab — Phase 3
Clinical update -
Mirvetuximab Soravtansine — Phase 3
Clinical update -
methotrexate (MTX) — Approved
Clinical update
Trial registry
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗